These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26703218)

  • 21. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of granulocyte colony stimulating factor (G-CSF) and granulocyte/macrophage colony stimulating factor (GM-CSF) mRNA upon stimulation with phorbol ester.
    Kothari SS; Abrahamsen MS; Cole T; Hammond WP
    Blood Cells Mol Dis; 1995; 21(3):192-200. PubMed ID: 8673471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
    Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
    Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.
    Hamilton JA; Whitty GA; Royston AK; Cebon J; Layton JE
    Immunology; 1992 Aug; 76(4):566-71. PubMed ID: 1383133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation.
    Bharadwaj U; Li M; Zhang R; Chen C; Yao Q
    Cancer Res; 2007 Jun; 67(11):5479-88. PubMed ID: 17545630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.
    Lv M; Zhao XS; Hu Y; Chang YJ; Zhao XY; Kong Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Am J Hematol; 2015 Jan; 90(1):E9-E16. PubMed ID: 25303038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.
    Teshima T; Mach N; Hill GR; Pan L; Gillessen S; Dranoff G; Ferrara JL
    Cancer Res; 2001 Jan; 61(1):162-71. PubMed ID: 11196155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte colony-stimulating factor mobilizes more dendritic cell subsets than granulocyte-macrophage colony-stimulating factor with no polarization of dendritic cell subsets in normal donors.
    Shaughnessy PJ; Bachier C; Lemaistre CF; Akay C; Pollock BH; Gazitt Y
    Stem Cells; 2006 Jul; 24(7):1789-97. PubMed ID: 16822885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation.
    Vela-Ojeda J; Montiel-Cervantes L; Granados-Lara P; Reyes-Maldonado E; García-Latorre E; Garcia-Chavez J; Majluf-Cruz A; Mayani H; Borbolla-Escoboza JR; Esparza MG
    Stem Cells Dev; 2010 Mar; 19(3):333-40. PubMed ID: 19919293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
    Seggewiss R; Einsele H
    Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression profiles of adhesion molecules on naïve T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factor.
    Chang YJ; Zhao XY; Huo MR; Huang XJ
    Transpl Immunol; 2009 Sep; 21(4):228-33. PubMed ID: 19467326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus.
    Sivakumar R; Abboud G; Mathews CE; Atkinson MA; Morel L
    Front Immunol; 2018; 9():1053. PubMed ID: 29868014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha.
    Rutella S; Bonanno G; Pierelli L; Mariotti A; Capoluongo E; Contemi AM; Ameglio F; Curti A; De Ritis DG; Voso MT; Perillo A; Mancuso S; Scambia G; Lemoli RM; Leone G
    Eur J Immunol; 2004 May; 34(5):1291-302. PubMed ID: 15114662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.
    Janikashvili N; Trad M; Gautheron A; Samson M; Lamarthée B; Bonnefoy F; Lemaire-Ewing S; Ciudad M; Rekhviashvili K; Seaphanh F; Gaugler B; Perruche S; Bateman A; Martin L; Audia S; Saas P; Larmonier N; Bonnotte B
    J Allergy Clin Immunol; 2015 Jun; 135(6):1614-24.e4. PubMed ID: 25630940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GM-CSF alters dendritic cells in autoimmune diseases.
    Li BZ; Ye QL; Xu WD; Li JH; Ye DQ; Xu Y
    Autoimmunity; 2013 Nov; 46(7):409-18. PubMed ID: 23786272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.